Area of research
Cancer Research · Molecular Biology
Research interest
Research topics from publications: Luteolin exerts an anticancer effect on gastric cancer cells through multiple signaling pathways and regulating miRNAs; LncRNA LINC02253 activates KRT18/MAPK/ERK pathway by mediating N6-methyladenosine modification of KRT18 mRNA in gastric cancer; LRP4 promotes migration and invasion of gastric cancer under the regulation of microRNA-140-5p; MicroRNA-582 promotes tumorigenesis by targeting phosphatase and tensin homologue in colorectal cancer; Genetic variants in TERT are associated with risk of gastric cancer in a Chinese Han population. Representative work: Accumulating studies confirmed that luteolin, a common dietary flavonoid which is widely distributed in plants and has diverse beneficial biological function, including anti-oxidant, anti-inflammation and anticancer properties. However, the detail mechanisms of luteolin on GC are poorly understood. Here, we investigated the anticancer effect of luteolin in GC cells in vitro and in vivo. Luteolin reduced the cell viability in a time and dose-dependent manner. Luteolin significantly inhibited cell cycle progress, colony formation, proliferation, migration, invasion and promoted apoptosis in vitro and in vivo. Luteolin also regulated these biological effects associated regulators. Mechanically, Long non-coding RNAs (lncRNAs) play a crucial role in gastric cancer (GC) progression. And understanding the role of N6-methyladenosine (m6A) in tumorigenesis is an emerging field in cancer research. Here, we identified a novel oncogene, lncRNA LINC02253, in GC. LINC02253 expression was found to be significantly increased in GC. And LINC02253 expression was closely correlated with tumor size, lymph node metastasis and TNM stage of GC. Besides, GC patients with higher LINC02253 expression had worse 5-year overall survival. Additionally, LINC02253 promoted GC cell growth, migration and invasion both in vitro and in vivo. Mechanistically, we determined that LINC02253 increased KRT18 expression
LncRNA LINC02253 activates KRT18/MAPK/ERK pathway by mediating <i>N</i>6-methyladenosine modification of KRT18 mRNA in gastric cancer
LRP4 promotes migration and invasion of gastric cancer under the regulation of microRNA-140-5p
Luteolin exerts an anticancer effect on gastric cancer cells through multiple signaling pathways and regulating miRNAs
MicroRNA-582 promotes tumorigenesis by targeting phosphatase and tensin homologue in colorectal cancer
Genetic variants in <i>TERT</i> are associated with risk of gastric cancer in a Chinese Han population